Last updated on April 2019

A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer

Brief description of study

The purpose of this study is to determine the safety and efficacy of nab-paclitaxel and gemcitabine with or without olaratumab in the treatment of first-line metastatic pancreatic cancer.

Clinical Study Identifier: NCT03086369

Find a site near you

Start Over

Chattanooga Oncology Hematology Associates

Chattanooga, TN United States
  Connect »